Viruses and Toll-like receptors

Microbes and Infection

Volumn 5, Issue 11, 2003, Pages 961-968

  Rassa, John C ^a   Ross, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Herpesvirus; Paramyxovirus; Poxvirus; Retrovirus; Toll like receptor

Indexed keywords

TOLL LIKE RECEPTOR;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; CYTOMEGALOVIRUS; DEFECTIVE VIRUS; EMBRYO DEVELOPMENT; GENE FUNCTION; HERPES VIRUS; HOST PATHOGEN INTERACTION; LYMPHOCYTE ACTIVATION; MEASLES VIRUS; MOLECULAR CLONING; MOUSE MAMMARY TUMOR ONCOVIRUS; MUMPS VIRUS; NONHUMAN; PARAMYXOVIRUS; POXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

HERPESVIRIDAE; PARAMYXOVIRIDAE; POXVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0042572276     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00193-X     Document Type: Review

References (69)

1. Hsu E.C., Iorio C., Sarangi F., Khine A.A., Richardson C.D. CD150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology. 279:2001;9-21.
2. Tatsuo H., Ono N., Tanaka K., Yanagi Y. SLAM (CD150) is a cellular receptor for measles virus. Nature. 406:2000;893-897.
3. Dorig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
4. Sugano N., Chen W., Roberts M.L., Cooper N.R. Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-κB induction. J. Exp. M. 186:1997;731-737.
5. Liu Q.H., Williams D.A., McManus C., Baribaud F., Doms R.W., Schols D., De Clercq E., Kotlikoff M.I., Collman R.G., Freedman B.D. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc. Natl. Acad. Sci. USA. 97:2000;4832-4837.
6. Weissman D., Rabin R.L., Arthos J., Rubbert A., Dybul M., Swofford R., Venkatesan S., Farber J.M., Fauci A.S. Macrophage-tropic HIVand SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389:1997;981-985.
7. Lalani A.S., Masters J., Wang W., Barrett J., Rannu R., Everett H., Arendt C.W., McFadden G. Use of chemokine receptors by poxviruses. Science. 286:1999;1968-1971.
8. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
9. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:2001;135-145.
10. Lemaitre B., Nicolas E., Michaut L., Reichhart J.-M., Hoffmann J.A. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
11. Dinesh-Kumar S.P., Tham W.-H., Baker B.J. Structure-function analysis of the tobacco mosaic virus resistance gene N. Proc. Natl. Acad. Sci. USA. 97:2000;14789-14794.
12. Bendahmane A., Kanyuka K., Baulcombe D.C. The Rx gene from potato controls separate virus resistance and cell death responses. Plant Cell. 11:1999;781-792.
13. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
14. Poltorak A., He X., Smirnova I., Liu M.-Y., van Huffel C., Ku X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciarid-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in tlr4 gene. Science. 282:1998;2085-2088.
15. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. M. 189:1999;615-625.
16. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85:2003;85-95.
17. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjai A.M., Smith K.D., Wilson C.B., Schroeder L., Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA. 97:2000;13766-13771.
18. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J., Wilson C.B. Functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in reponse to phenol-soluble modulin. J. Immunol. 166:2001;15-19.
19. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
20. Horng T., Barton G.M., Medzhitov R. TIRAP: an adaptor molecule in the Toll signalling pathway. Nat. Immunol. 2:2001;835-841.
21. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., Mc Murray D., Smith D.E., Sims J.E., Bird T.A., O'Neill L.A. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
22. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:2002;6668-6672.
23. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4:2003;161-167.
24. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signaling specificity for Toll-like receptors. Nature. 420:2002;329-333.
25. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., Takeda K., Akira S. Essential role for TIRAP in activation of the signaling cascade shared by TLR2 and TLR4. Nature. 420:2002;324-329.
26. Servant M.J., Grandvaux N., Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharm. 64:2002;985-992.
27. Kawai T., Takeuchi O., Fujita T., Inoue J.-I., Muhlradt P.F., Sato S., Hoshino K., Akira S. Lipopolysaccharide stimulates the Myd88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:2001;5887-5894.
28. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., Shizuo A. Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14:2002;1225-1231.
29. Doyle S.E., Vaidya S.A., O'Connell R., Dadgostar H., Dempsey P.W., Wu T.-T., Rao G., Sun R., Haberland M.E., Modlin R.L., Cheng G. IRF3 mediates a TLR3/TLR4-specific anti-viral gene program. Immunity. 17:2002;251-263.
30. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2:2001;349-355.
31. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
32. Barton G.M., Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr. Opinion Immunol. 14:2002;380-383.
33. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:2001;947-950.
34. Sieling P.A., Chung W., Duong B.T., Godowski P.J., Modlin R.L. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J. Immunol. 170:2003;194-200.
35. Dabbagh K., Dahl M.E., Stepick-Biek P., Lewis D.B. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immunol. 168:2002;4524-4530.
36. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. M. 196:2002;1645-1651.
37. Sing A., Roggenkamp A., Geiger A.M., Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 169:2002;1315-1321.
38. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., Aefelbacher M., Heesemann J. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. M. 196:2002;1017-1024.
39. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.
40. Haynes L.M., Moore D.D., Kurt-Jones E.A., Finberg R.W., Anderson L.J., Tripp R.A. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:2001;10730-10737.
41. Haeberle H.A., Takizawa R., Casola A., Brasier A.R., Dieterich H.J., Van Rooijen N., Gatalica Z., Garofalo R.P. Respiratory syncytial virus-induced activation of nuclear factor-κB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Inf. Dis. 186:2002;1199-1206.
42. Poltorak A., Merlin T., Nielsen P.J., Sandra O., Smirnova I., Schupp I., Boehm T., Galanos C., Freudenberg M.A. A point mutation in the IL-12Rβ2 gene underlies the IL-12 unresponsiveness of LPS-defective C57BL/10ScCr mice. J. Immunol. 167:2001;2106-2111.
43. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., Grant McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:2003;377-423.
44. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA. 97:2000;10162-10167.
45. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 408:2000;111-115.
46. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., O'Neill L. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defence. J. Exp. M. 197:2003;343-351.
47. van den Broek M.F., Muller U., Huang S., Zinkernagel R.M., Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:1995;5-18.
48. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:1999;6762-6768.
49. Harel J., Rassart E., Jolicoeur P. Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus. Virology. 110:1981;202-207.
50. Roe T., Reynolds T.C., Yu G., Brown P.O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:1993;2099-2108.
51. Ross S.R. Using genetics to probe host-virus interactions: the mouse mammary tumor virus model. Microb. Infect. 2:2000;1215-1223.
52. Outzen H.C., Morrow D., Shultz L.D. Attenuation of exogenous murine mammary tumor virus virulence in the C3H/HeJ mouse substrain bearing the LPS mutation. J. Natl. Canc. Inst. 75:1985;917-923.
53. n gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162:1999;5666-5670.
54. Ardavin C., Luthi F., Andersson M., Scarpellino L., Martin P., Diggelmann H., Acha-Orbea H. Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model. J. Virol. 71:1997;7295-7299.
55. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., Ross S.R. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA. 99:2002;2281-2286.
56. King L.B., Corley R.B. Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways. Mol. Cell Biol. 10:1990;4211-4220.
57. Jude B.A., Pobezinskaya Y., Bishop J., Parke S., Medzhitov R.M., Chervonsky A.V., Golovkina T.V. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4:2003;537-538.
58. Hook L.M., Agafonova Y., Ross S.R., Turner S.J., Golovkina T.V. Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene. J. Virol. 74:2000;8876-8883.
59. Klagge I.M., Schneider-Schaulies S. Virus interactions with dendritic cells. J. Gen. Virol. 80:1999;823-833.
60. Helin E., Vainionpaa R., Hyypia T., Julkunen I., Matikainen S. Measles virus activates NF-kappaB and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology. 290:2001;1-10.
61. Schnorr J.J., Xanthakos S., Keikavoussi P., Kaempgen E., ter Meulen V., Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. USA. 94:1997;5326-5331.
62. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., Wagner H., Kirschning C.J., ter Meulen V., Schneider-Schaulies S. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76:2002;8729-8736.
63. Murabayashi N., Kurita-Taniguchi M., Ayata M., Matsumoto M., Ogura H., Seya T. Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CD150: role of Toll stimumlators in DC maturation and MV amplification. Microb. Infect. 4:2002;785-794.
64. Zhu H., Cong J.P., Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. USA. 94:1997;13985-13990.
65. Simmen K.A., Singh J., Luukkonen B.G., Lopper M., Bittner A., Miller N.E., Jackson M.R., Compton T., Fruh K. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. USA. 98:2001;7140-7145.
66. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:2003;4588-4596.
67. Holt B.F., Hubert D.A., Dangl J.L. Resistance gene signaling in plants - complex similarities to animal innate immunity. Curr. Opinion Immun. 15:2003;20-25.
68. Kobe B., Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J. Mol. Biol. 264:1996;1028-1043.
69. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:2000;531-569.